M	O
-	O
CSF	O
signals	O
through	O
the	O
MAPK	O
/	O
ERK	O
pathway	O
via	O
Sp1	O
to	O
induce	O
VEGF	O
production	O
and	O
induces	O
angiogenesis	O
in	O
vivo	O
.	O

BACKGROUND	O
:	O
M	O
-	O
CSF	O
recruits	O
mononuclear	B-Cell
phagocytes	I-Cell
which	O
regulate	O
processes	O
such	O
as	O
angiogenesis	O
and	O
metastases	B-Cancer
in	O
tumors	B-Cancer
.	O

VEGF	O
is	O
a	O
potent	O
activator	O
of	O
angiogenesis	O
as	O
it	O
promotes	O
endothelial	B-Cell
cell	I-Cell
proliferation	O
and	O
new	O
blood	B-Multi-tissue_structure
vessel	I-Multi-tissue_structure
formation	O
.	O

Previously	O
,	O
we	O
reported	O
that	O
in	O
vitro	O
M	O
-	O
CSF	O
induces	O
the	O
expression	O
of	O
biologically	O
-	O
active	O
VEGF	O
from	O
human	O
monocytes	B-Cell
.	O

METHODOLOGY	O
AND	O
RESULTS	O
:	O
In	O
this	O
study	O
,	O
we	O
demonstrate	O
the	O
molecular	O
mechanism	O
of	O
M	O
-	O
CSF	O
-	O
induced	O
VEGF	O
production	O
.	O

Using	O
a	O
construct	O
containing	O
the	O
VEGF	O
promoter	O
linked	O
to	O
a	O
luciferase	O
reporter	O
,	O
we	O
found	O
that	O
a	O
mutation	O
reducing	O
HIF	O
binding	O
to	O
the	O
VEGF	O
promoter	O
had	O
no	O
significant	O
effect	O
on	O
luciferase	O
production	O
induced	O
by	O
M	O
-	O
CSF	O
stimulation	O
.	O

Further	O
analysis	O
revealed	O
that	O
M	O
-	O
CSF	O
induced	O
VEGF	O
through	O
the	O
MAPK	O
/	O
ERK	O
signaling	O
pathway	O
via	O
the	O
transcription	O
factor	O
,	O
Sp1	O
.	O

Thus	O
,	O
inhibition	O
of	O
either	O
ERK	O
or	O
Sp1	O
suppressed	O
M	O
-	O
CSF	O
-	O
induced	O
VEGF	O
at	O
the	O
mRNA	O
and	O
protein	O
level	O
.	O

M	O
-	O
CSF	O
also	O
induced	O
the	O
nuclear	B-Cellular_component
localization	O
of	O
Sp1	O
,	O
which	O
was	O
blocked	O
by	O
ERK	O
inhibition	O
.	O

Finally	O
,	O
mutating	O
the	O
Sp1	O
binding	O
sites	O
within	O
the	O
VEGF	O
promoter	O
or	O
inhibiting	O
ERK	O
decreased	O
VEGF	O
promoter	O
activity	O
in	O
M	O
-	O
CSF	O
-	O
treated	O
human	O
monocytes	B-Cell
.	O

To	O
evaluate	O
the	O
biological	O
significance	O
of	O
M	O
-	O
CSF	O
induced	O
VEGF	O
production	O
,	O
we	O
used	O
an	O
in	O
vivo	O
angiogenesis	O
model	O
to	O
illustrate	O
the	O
ability	O
of	O
M	O
-	O
CSF	O
to	O
recruit	O
mononuclear	B-Cell
phagocytes	I-Cell
,	O
increase	O
VEGF	O
levels	O
,	O
and	O
enhance	O
angiogenesis	O
.	O

Importantly	O
,	O
the	O
addition	O
of	O
a	O
neutralizing	O
VEGF	O
antibody	O
abolished	O
M	O
-	O
CSF	O
-	O
induced	O
blood	B-Multi-tissue_structure
vessel	I-Multi-tissue_structure
formation	O
.	O

CONCLUSION	O
:	O
These	O
data	O
delineate	O
an	O
ERK	O
-	O
and	O
Sp1	O
-	O
dependent	O
mechanism	O
of	O
M	O
-	O
CSF	O
induced	O
VEGF	O
production	O
and	O
demonstrate	O
for	O
the	O
first	O
time	O
the	O
ability	O
of	O
M	O
-	O
CSF	O
to	O
induce	O
angiogenesis	O
via	O
VEGF	O
in	O
vivo	O
.	O

